Weight Management

Semaglutide vs. Tirzepatide: How They Compare

A clinical comparison of semaglutide and tirzepatide for weight loss — mechanism, trial results, and side effect differences.

Published August 30, 2026

Semaglutide and tirzepatide are the two GLP-1 medications most often discussed for medical weight management. This article compares how they work and where side effects differ. If you are considering treatment, see our medical weight loss program, where a licensed provider decides whether either medication is appropriate for you.

Different Mechanisms

Semaglutide activates only the GLP-1 receptor. Tirzepatide is a dual agonist — it activates both the GLP-1 and GIP receptors, targeting two hormone pathways involved in appetite and blood sugar regulation instead of one.

What the Head-to-Head Trial Found

The most direct comparison comes from the SURMOUNT-5 clinical trial, which put the two medications against each other directly. At 72 weeks, participants on tirzepatide lost an average of 20.2% of body weight, compared to 13.7% for semaglutide.^[1] Results like these come from controlled trial populations — individual results vary, and this isn't a promise of what any one patient will experience.

Where Side Effects Differ

Both medications carry gastrointestinal side effects — nausea and diarrhea are the most common with either. Research comparing them found tirzepatide carries a somewhat higher risk of nausea and diarrhea than semaglutide.^[2] Semaglutide, on the other hand, carries an elevated risk of gallbladder-related issues (cholelithiasis) — one real-world study found a 1.4x relative risk compared to patients not on the medication.^[3] Neither risk profile is negligible, and both are exactly the kind of thing a provider evaluates against your specific health history before prescribing either one.

How Your Provider Decides

Tirzepatide's dual mechanism tends to produce greater average weight loss and broader metabolic improvements (blood pressure, cholesterol, blood sugar), while semaglutide has a longer track record, including established cardiovascular outcome data.^[4] Neither is universally "better" — the right choice depends on your health history, goals, and how your provider weighs these tradeoffs for you specifically.

Getting Started

Complete an intake, get reviewed by a licensed provider, and if appropriate, start treatment.

Start Your Weight Loss Evaluation